Ortho-McNeil will market Biovail's tramadol formulations
Executive Summary
J&J's Ortho-McNeil has agreed to handle US marketing (including Puerto Rico) for two formulations of the opioid pain drug tramadol that were developed by drug delivery firm Biovail Corp. and approved earlier this year.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice